Identification of 2-oxo-N-(phenylmethyl)-4-imidazolidinecarboxamide antagonists of the P2X7 receptor
作者:Lee Abberley、Aude Bebius、Paul J. Beswick、Andy Billinton、Katharine L. Collis、David K. Dean、Elena Fonfria、Robert J. Gleave、Stephen J. Medhurst、Anton D. Michel、Andrew P. Moses、Sadhana Patel、Shilina A. Roman、Tiziana Scoccitti、Beverley Smith、Jon G.A. Steadman、Daryl S. Walter
DOI:10.1016/j.bmcl.2010.09.101
日期:2010.11
by targeting the most likely metabolically vulnerable site in this molecule. Compound 18 was subsequently identified as a potent P2X7 antagonist with very low in vivo clearance and high oral bioavailability in all species examined. Some evidence to support the role of P2X7 in the etiology of pain is also presented.
通过靶向该分子中最可能的代谢脆弱位点来寻找化合物2的备用分子。随后将化合物18鉴定为有效的P2X 7拮抗剂,在所有检查的物种中均具有极低的体内清除率和较高的口服生物利用度。还提供了一些证据来支持P2X 7在疼痛病因中的作用。